Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Flupentixol and Melitracen Tablets
- Product Name
- 氟哌噻吨美利曲辛片
- Approval Number
- 国药准字H20143390
- Approval Date
- Oct 18, 2024
NMPA
Flupentixol Dihydrochloride
- Product Name
- 盐酸氟哌噻吨
- Approval Number
- 国药准字H20140131
- Approval Date
- Oct 16, 2024
NMPA
Dapoxetine Hydrochloride Tablets
- Product Name
- 盐酸达泊西汀片
- Approval Number
- 国药准字H20233362
- Approval Date
- Mar 24, 2023
NMPA
Clinical Trials
No trials found
News
No news found